Earlier this month Danish drugmaker Novo Nordisk launched its oral Wegovy weight-loss pill in the US, for "needle-averse patients". The starting dose is priced at $149 a month for patients paying in ...

Several Indian companies are preparing to launch generic versions of GLP-1 category drug Semaglutide in India ...

Billboard has announced an upcoming shift in its chart tabulation that will give more weight to music streaming against album sales. Starting in January, the magazine and authoritative record of music ...

The change is being implemented to reflect an increase in streaming revenue, along with changing music consumption behaviors. By Billboard Staff Starting in January, the Billboard charts will add more ...

Ontario’s tire recycling program has slowed to a crawl following the Ford government’s decision to lower recycling targets earlier this year. Thousands of old tires are now being stockpiled as ...

Ahead of its Capital Markets Day Thursday, Zealand Pharma unveiled its "Metabolic Frontier 2030" strategy. The strategy comes as Zealand shares have dropped 29% year to date, with investors betting on ...

Weight Loss Trends 2025: The biggest fitness trend of 2025 was simple — people chose routines that were easy, enjoyable, and stress-free. Strict diets and exhausting workout regimes took a backseat, ...

As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...

LONDON/COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk is facing a major challenge to its blockbuster weight-loss drug Wegovy. Booming sales of Wegovy powered the firm to become Europe's most ...